0001013606-19-000170.txt : 20191001 0001013606-19-000170.hdr.sgml : 20191001 20191001163056 ACCESSION NUMBER: 0001013606-19-000170 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190927 FILED AS OF DATE: 20191001 DATE AS OF CHANGE: 20191001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mahboob Vaseem CENTRAL INDEX KEY: 0001655157 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28440 FILM NUMBER: 191129491 MAIL ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENDOLOGIX INC /DE/ CENTRAL INDEX KEY: 0001013606 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680328265 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 9495984741 MAIL ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: RADIANCE MEDICAL SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19990122 FORMER COMPANY: FORMER CONFORMED NAME: CARDIOVASCULAR DYNAMICS INC DATE OF NAME CHANGE: 19960506 4 1 wf-form4_156996183385541.xml FORM 4 X0306 4 2019-09-27 0 0001013606 ENDOLOGIX INC /DE/ ELGX 0001655157 Mahboob Vaseem 2 MUSICK IRVINE CA 92618 0 1 0 0 Chief Financial Officer Option to Purchase 135.6 2019-09-27 4 D 0 13702 0 D 2016-10-15 2025-10-15 Common Stock 13702.0 0 D Option to Purchase 75.3 2019-09-27 4 D 0 11594 D 2016-03-04 2026-02-04 Common Stock 11594.0 0 D Option to Purchase 48.2 2019-09-27 4 D 0 10999 D 2017-06-30 2027-05-31 Common Stock 10999.0 0 D Option to Purchase 4.71 2019-09-27 4 A 0 10959 A 2020-09-10 2026-09-10 Common Stock 10959.0 10959 D Twenty-five percent of the options vested upon one year of service and the remaining balance continued to vest in equal monthly installments thereafter. The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, (i) an option for 13,702 shares of common stock granted to the reporting person on October 15, 2015, (ii) an option for 11,594 shares of common stock granted to the reporting person on February 4, 2016, and (iii) an option for 10,999 shares of common stock granted to the reporting person on May 31, 2017. In exchange, the reporting person received a new stock option, for 10,959 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019. Options vested ratably over forty-eight months. The options vest in three equal annual installments over a three-year period commencing on September 10, 2019. Vaseem Mahboob by Timothy N. Brady Attorney-in-Fact for Reporting Person 2019-10-01